8 Results

People

  1. Zelenetz
    Zelenetz
  2. Palomba
    Palomba
  3. Batlevi
    Batlevi
  4. Falchi
    Falchi
  5. Mato
    Mato
  6. Noy
    Noy
  7. Salles
    Salles
  8. Vardhana
    Vardhana
  9. Abdel-Wahab
    Abdel-Wahab
  10. Caron
    Caron

Groups

  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. GSK Faculty (8)
  4. Hematologic Malignancies, Division of (8)
  5. Lymphoma (8)
  6. Human Oncology and Pathogenesis Program (7)
  7. GME, Medicine (6)
  8. Graduate Medical Education (6)
  9. Executive Committee, Center for Hematologic Malignancies (5)
  10. Adult Leukemia (4)
  1. "Center for Hematologic Malignancies"
  2. "Andrew Zelenetz"
  3. "GSK Faculty"
  4. "2022"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. GSK Faculty (8)
  4. Hematologic Malignancies, Division of (8)
  5. Lymphoma (8)
  6. Human Oncology and Pathogenesis Program (7)

More Groups

People
  1. Andrew Zelenetz (8)
  2. Maria Palomba (6)
  3. Anthony Mato (4)
  4. Ariela Noy (4)
  5. Connie Batlevi (4)
  6. David Straus (4)

More People

Years
  1. 2022 (8)
Publications
  1. Blood (6)
  2. Cancer Cell (1)
  3. New England Journal of Medicine (1)
Publishers
  1. American Society of Hematology (6)
  2. Cell Press (1)
  3. Massachusetts Medical Society (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of therapies and resistance mutations following non-covalent Bruton's Tyrosine Kinase inhibitor treatment for patients with chronic lymphocytic leukemia and Richter Transformation
    Meeting Abstract

    Thompson, M. C.; Coombs, C. C.; Roeker, L. E.; Jensen, J. L.; Shah, N. N.; Luo, T.; Patel, K.; Bailey, N.; Fakhri, B.; Eyre, T. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Characterization of a large cohort of patients with nodal marginal zone lymphoma shows prolonged survival, time-to-treatment, and time-to-transformation
    Meeting Abstract

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing
    Meeting Abstract

    Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Long-term outcome of patients with follicular lymphoma is not fundamentally affected by KMT2D, EZH2, and CREBBP mutational status
    Meeting Abstract

    Bantilan, K. S.; Rutherford, K.; McCarter, J.; Farnoud, N.; Arango-Ossa, J. E.; Papaemmanuil, E.; Zelenetz, A. D.
    Blood (2022)

    Fulltext@MSK | Save
  • Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders
    Meeting Abstract

    Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Mechanisms of resistance to noncovalent Bruton's tyrosine kinase inhibitors
    Journal Article

    Wang, E.; Mi, X.; Thompson, M. C.; Montoya, S.; Notti, R. Q.; Afaghani, J.; Durham, B. H.; Penson, A.; Witkowski, M. T.; Lu, S. X.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save